These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 11511167)
1. Disproportionation of a model chromium(V) complex causes extensive chromium(III)-DNA binding in vitro. Levina A; Lay PA; Dixon NE Chem Res Toxicol; 2001 Aug; 14(8):946-50. PubMed ID: 11511167 [TBL] [Abstract][Full Text] [Related]
2. Disproportionation and nuclease activity of bis[2-ethyl-2-hydroxybutanoato(2-)]oxochromate(V) in neutral aqueous solutions. Levina A; Lay PA; Dixon NE Inorg Chem; 2000 Feb; 39(3):385-95. PubMed ID: 11229553 [TBL] [Abstract][Full Text] [Related]
3. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049 [TBL] [Abstract][Full Text] [Related]
4. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI). Zhitkovich A; Quievryn G; Messer J; Motylevich Z Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121 [TBL] [Abstract][Full Text] [Related]
5. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Zhitkovich A; Song Y; Quievryn G; Voitkun V Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050 [TBL] [Abstract][Full Text] [Related]
6. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. O'Brien T; Mandel HG; Pritchard DE; Patierno SR Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844 [TBL] [Abstract][Full Text] [Related]
7. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Quievryn G; Peterson E; Messer J; Zhitkovich A Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927 [TBL] [Abstract][Full Text] [Related]
8. Spectroscopic characterization of genotoxic chromium(V) peptide complexes: Oxidation of Chromium(III) triglycine, tetraglycine and pentaglycine complexes. Headlam HA; Lay PA J Inorg Biochem; 2016 Sep; 162():227-237. PubMed ID: 27365280 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis of lymphocytes induced by chromium(VI/V) is through ROS-mediated activation of Src-family kinases and caspase-3. Vasant C; Rajaram R; Ramasami T Free Radic Biol Med; 2003 Nov; 35(9):1082-100. PubMed ID: 14572611 [TBL] [Abstract][Full Text] [Related]
10. Differential impact of ionic and coordinate covalent chromium (Cr)-DNA binding on DNA replication. Fornsaglio JL; O'Brien TJ; Patierno SR Mol Cell Biochem; 2005 Nov; 279(1-2):149-55. PubMed ID: 16283524 [TBL] [Abstract][Full Text] [Related]
11. Formation and reactivity of chromium(V)-thiolato complexes: a model for the intracellular reactions of carcinogenic chromium(VI) with biological thiols. Levina A; Zhang L; Lay PA J Am Chem Soc; 2010 Jun; 132(25):8720-31. PubMed ID: 20527748 [TBL] [Abstract][Full Text] [Related]
12. Chromium(VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro. Stearns DM; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):21-5. PubMed ID: 7843100 [TBL] [Abstract][Full Text] [Related]
17. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage. Zhitkovich A; Shrager S; Messer J Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433 [TBL] [Abstract][Full Text] [Related]
18. Direct evidence for hydroxyl radical-induced damage to nucleic acids by chromium(VI)-derived species: implications for chromium carcinogenesis. Molyneux MJ; Davies MJ Carcinogenesis; 1995 Apr; 16(4):875-82. PubMed ID: 7537182 [TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization, and nuclease activity of biologically relevant chromium(V) complexes with monosaccharides and model diols. Likely intermediates in chromium-induced cancers. Bartholomäus R; Irwin JA; Shi L; Smith SM; Levina A; Lay PA Inorg Chem; 2013 Apr; 52(8):4282-92. PubMed ID: 23531300 [TBL] [Abstract][Full Text] [Related]
20. Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity. Marchi S; Lankford E; Dorin B; Drummond E; Thomas SC; Woski SA; Vincent JB Biol Trace Elem Res; 2023 Oct; 201(10):5053-5066. PubMed ID: 36662348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]